The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

  • This share is currently suspended. It was suspended at a price of 5.375

Share Price Information for Iconic Labs (ICON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.375
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.375
ICON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Infotagion Update

8 Apr 2020 09:37

RNS Number : 2064J
Iconic Labs PLC
08 April 2020
 

 

 

8 April 2020

 

 

Iconic Labs Plc ("Iconic Labs" or the "Company")

Media Launch of Infotagion is Viewed by 1million readers

 

Iconic Labs Plc (LSE:ICON) (the "Company"), a multi-divisional new media and technology business, announces the successful launch of Infotagion by reaching 1million readers.

 

The Company announced last week that, in partnership with Damian Collins MP, former Chair of the Parliamentary Committee on Culture, Media and Sport, it had established a service to counter the dissemination of incorrect information, in particular through social media, that relates to the Covid-19 pandemic and its related economic and social effects.

 

In just a matter of days the media launch resulted in more than 70 pieces of individual news covered by the UK's major news outlets including the BBC, ITV, Daily Mail, WIRED, Yahoo, radio and local and specialist news sites.

 

The phenomenal success of the media launch meant that at least 1million readers viewed the news; it was shared across social media nearly three thousand times and also verified by Facebook and Twitter.

 

The full list of media coverage surrounding Infotagion can be found here: https://www.iconiclabs.co.uk/infotagion-the-battle-against-disinformation/

 

In addition to this the group of supporters within governments and organisations around the world continues to grow and the full list is updated on the Infotagion website.

 

The company has been approached by a number of global organisations about using the Infotagion platform and data. The company looks forward to updating the market with the progress of these plans.

 

John Quinlan, Chief Executive Officer of Iconic Labs, said: ""We are delighted with the launch of Infotagion. To receive such a response in such a short period of time just goes to show how important this service is to the public. The support has been unprecedented and the platform is growing day by day. For Twitter and Facebook to verify us so quickly also shows a level of cooperation and trust from them and we thank them for their support. We plan to keep growing this platform and increasing the awareness of what Infotagion and Iconic Labs can achieve."

 

Social media is providing to be a very powerful and important asset to our communities in the current crisis. In particular it provides one the most effective means by which people can maintain essential interaction with others, and preserve communities, during this period of social distancing and isolation.

However, there is another side in that social media is one of the primary forums in which disinformation, whether circulated innocently or deliberately, is prevalent. We are therefore very pleased to be able to play a role in helping to counter disinformation about the current Covid-19 pandemic by bringing our expertise and skills to bear on the problem."

 

Infotagion

 

The core of the service is a website (www.infotagion.co.uk ) on which users post screenshots of information which they have received from social media or elsewhere. The submitted information is checked by a team organised by Mr Collins, which includes experts from, inter alia, the WHO and Parliament.

 

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

**ENDS**

 

For further information, please visit the Company's website www.iconiclabs.co.uk or contact:

 

Damon Heath

Shard Capital Partners LLP

Tel: +44 (0) 20 7186 9950

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDSSDSAAESSEDL
Date   Source Headline
1st May 20194:35 pmRNSPrice Monitoring Extension
1st May 20194:05 pmRNSCorporate Update
1st May 20194:00 pmRNSFinancing Agreement
29th Apr 20192:15 pmRNSHolding(s) in Company
29th Apr 201911:07 amRNSSecond Price Monitoring Extn
29th Apr 201911:00 amRNSPrice Monitoring Extension
29th Apr 201910:38 amRNSTR-1: NOTIFICATION OF MAJOR HOLDINGS 
29th Apr 201910:29 amRNSConversion of Loan Notes & Issue of Shares
29th Apr 201910:14 amRNSTR1 Align Research
26th Apr 201911:05 amRNSHolding(s) in Company
26th Apr 201911:00 amRNSHolding(s) in Company
25th Apr 201910:30 amRNSUpdate on Option
23rd Apr 201911:30 amRNSHolding(s) in Company
17th Apr 201910:05 amRNSHolding(s) in Company
17th Apr 201910:00 amRNSHolding(s) in Company
16th Apr 201912:45 pmRNSHolding(s) in Company
12th Apr 201911:35 amRNSDirector's Interest
12th Apr 201911:30 amRNSHolding(s) in Company
8th Apr 201910:10 amRNSHolding(s) in Company
5th Apr 201912:15 pmRNSHolding(s) in Company
5th Apr 201912:10 pmRNSHolding(s) in Company
3rd Apr 20195:37 pmRNSHolding(s) in Company
2nd Apr 201910:15 amRNSUpdate
21st Mar 20195:02 pmRNSHolding(s) in Company
21st Mar 20195:01 pmRNSUpdate
21st Mar 20195:00 pmRNSHolding(s) in Company
21st Mar 20197:00 amRNSOne2One Investor Forum
19th Mar 20191:42 pmRNSHolding(s) in Company
19th Mar 20191:41 pmRNSHolding(s) in Company
18th Mar 20192:05 pmRNSSecond Price Monitoring Extn
18th Mar 20192:00 pmRNSPrice Monitoring Extension
18th Mar 201911:45 amRNSHolding(s) in Company
18th Mar 20199:05 amRNSSecond Price Monitoring Extn
18th Mar 20199:00 amRNSPrice Monitoring Extension
18th Mar 20197:00 amRNSNew Media Business Created
14th Mar 201910:47 amRNSHolding(s) in Company
14th Mar 201910:46 amRNSUpdate
14th Mar 201910:45 amRNSHolding(s) in Company
12th Mar 20197:00 amRNSHolding(s) in Company
11th Mar 20198:48 amRNSHolding(s) in Company
8th Mar 20194:48 pmRNSHolding(s) in Company
8th Mar 20194:47 pmRNSUpdate
8th Mar 20194:46 pmRNSHolding(s) in Company
8th Mar 20194:45 pmRNSHolding(s) in Company
7th Mar 20192:05 pmRNSSecond Price Monitoring Extn
7th Mar 20192:00 pmRNSPrice Monitoring Extension
7th Mar 201911:00 amRNSPrice Monitoring Extension
6th Mar 20194:03 pmRNSUpdate
6th Mar 20192:00 pmRNSPrice Monitoring Extension
5th Mar 201911:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.